Skip to main content

Table 2 Demographics and Transplantation Information

From: A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation

 

High level FK778

Mid level FK778

Low level FK77

MMF

N = 87

N = 92

N = 92

N = 93

Age, mean (SD), y

47.1 (11.8)

48.2 (11.9)

44.9 (12)

46.8 (12.7)

Male, %

56.3

67.4

64.1

72

Caucasian, %

96.6

94.6

96.7

95.7

Viral status, n (%):

    

  HBV-positive

5 (5.7)

3 (3.3)

6 (6.5)

5 (5.4)

  CMV-positive a

58 (66.7)

57 (62)

55 (59.8)

65 (69.9)

  HCV-positive a

3 (3.4)

6 (6.5)

3 (3.3)

3 (3.2)

  EBV-positive a

47 (54)

45 (48.9)

48 (52.2)

53 (57)

CMV status: donor +/recipient-, n (%)

14 (18.2)

9 (11)

14 (16.9)

11 (12.6)

First renal transplant, n (%)

82 (94.3)

85 (92.4)

82 (89.1)

87 (93.5)

Deceased donor organ, n (%)

82 (94.3)

90 (97.8)

85 (92.4)

85 (91.4)

Cold ischemia time,

15.9 (6.5)

17.2 (6.3)

16.5 (6.7)

17.1 (7.2)

mean (SD), h

Donor age, mean (SD), y

47.2 (11.2)

44.7 (13.7)

42.9 (13)

43.5 (13.7)

Male organ donor, n (%)

42 (48.3)

57 (62)

58 (63)

61 (65.6)

Mean total HLA mismatch

2.7

2.8

2.5

2.6

  1. a Data on viral status are missing for some patients.